- Display 30 Products per page
Published: July 19, 2017 | Price: $3,360.00 – $6,720.00
Indonesia IVD Market Analysis Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics (IVD) manufacturers participating in Indonesia's marketplace. The following revenue information for 2017-2022 Indonesian IVD market segments is provided: Rapid Tests for Infectious Diseases by Category (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total) Microbiology (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies,...Published: July 7, 2017 | Price: $3,360.00 – $5,040.00
The Worldwide Market for Liquid Biopsy This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed. Companies covered Include: cfDNA-based Liquid Biopsy Adaptive Biotechnologies Biodesix Epigenomics Foundation Medicine Genomic Health Guardant Health Myriad Genetics Pathway Genomics Personal Genome...Published: June 23, 2017 | Price: $400.00 – $800.00
Published: June 23, 2017 | Price: $1,200.00 – $2,400.00
What is the market for information technology systems used in the expanding market for next-generation sequencing (NGS)? What companies are in this space, who are they partnering with and what products are they offering? This report examines the important contribution made by information technology to the use of next-generation sequencing, and to the markets for systems and consumables. As part of its coverage, the report provides the following: Indirect Market for Bioinformatics (Including Influence on Overall NGS Market) Trends Company...Published: June 22, 2017 | Price: $2,800.00 – $5,600.00
The PCR testing market, which includes other NAAT technologies, is a large and diverse market. This market consists of three segments: the life science (research) NAAT market, the clinical NAAT market, and an "other" segment that includes forensics, environmental monitoring, veterinary, and other applications that do not involve life science research or human clinical (medical) applications. This report provides market size, growth, product information, trends and segmentation for the clinical PCR market. Sizing is provided for 2016 and forecasts to...Published: June 16, 2017 | Price: $2,800.00 – $5,600.00
Brazil IVD Market Analysis Brazil IVD Market Analysis provides useful information to business planners including market size estimates for various segments, forecasts, competitive analysis, corporate profiles, market share and other information on the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of market segments, including: Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total) Brazil IVD Sales by Market Segment, 2016 Market Distribution...Published: June 14, 2017 | Price: $3,360.00 – $6,720.00
World Prescription Dermatological Drugs Market, 10th Edition (Antiacne and Rosacea, Antiaging and Photodamage, Dermatitis and Seborrhea, Antifungal, Hair Loss and Hair Removal, Hyperpigmentation/Melasma and Depigmenting, Psoriasis, Skin Cancer, and Miscellaneous Skin Disorder Drug Market) World Prescription Dermatological Drugs Market details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future.Published: June 9, 2017 | Price: $3,196.00 – $6,392.00
The Market for Blood Testing and TypingThis Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were...Published: May 26, 2017 | Price: $3,196.00 – $6,392.00
Lab Robotics Market analyzes the current and potential world revenues for diagnostic laboratory robotic systems. The report's revenue data provide multiple year forecasts for different product segments and revenue forecasts focus on segments where robotics plays an important role, including the following world market segments: The report's market data provide multiple year forecasts for different product segments and market forecasts focus on segments where robotics plays an important role, including the following world market segments: Specimen Transport Robots Systems, 2016-2021...Published: May 26, 2017 | Price: $200.00 – $400.00
This report describes major trends in the in vitro diagnostic industryPublished: May 15, 2017 | Price: $3,360.00 – $6,720.00
Potential Pipeline Disruptors: Innovative Pharmaceuticals in Alzheimer's Disease, Asthma and Cancer This report covers market opportunities based on pipeline developments for six key therapeutic specialities: Alzheimer's Disease Asthma Breast Cancer Leukemia Lung Cancer Lymphoma These six areas are expected to show the strongest pipeline impact and candidates are likely to replace current therapies. The market is evaluated for 2015 and 2016 with forecast data provided through 2022. Forecast data were derived from a combination of pipeline analyses, current product treatment...Published: May 11, 2017 | Price: $3,196.00 – $6,392.00
Virtual Reality and Augmented Reality (VR/AR) Market in Healthcare (U.S. Markets for Surgery; Medical Education and Training; Pain Management, Rehabilitation and Therapy) Virtual Reality and Augmented Reality (VR/AR) Market in Healthcare provides market analysis and examines applications for virtual reality (VR) and augmented reality (AR) in healthcare, including the following: • the Total US Market for VR/AR in Surgery (2012/2017/2022) • the Total US Market for VR/AR in Pain Management, Rehabilitation and Therapy (2012/2017/2022) • the Total US Market for...Published: May 5, 2017 | Price: $2,800.00 – $5,600.00
There are dozens of significant competitors in advanced wound care and hundreds of smaller companies. Growth rates can be competitive in some segments and new entrants are constantly entering the market. Innovation is a must in the quest to reduce hospital stays and get patients back to full activity. This report, Advanced Wound Care Market Analysis, provides a company-focused, industry-driven look at the state of advanced wound care market. Figures in this report are entirely from real-world company financials...Published: May 4, 2017 | Price: $2,800.00 – $5,600.00
The POC market is considered evolving with growthopportunity.  Developing and developedmarkets alike have room to grow due to an aging population worldwide. Key companies such as Roche, LifeScan,Abbott, and Alere will likely maintain leading positions in the market throughcontinued product innovation and strategic alliances and mergers.  This report profiles 50 companies that will determine the future of POC testing, and also provides market sizing and forecast for: • The Global Point-of-Care Market, 2016-2021 • The Global POC Market by Testing...Published: April 28, 2017 | Price: $2,000.00 – $4,000.00
Successful solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants require histocompatibility between the recipient and donor. Molecular Technologies can be of assistance in this process. Autologous transplantation using hematopoietic cells from the same patient (donor and recipient) is increasingly common and eliminates the need to screen for histocompatibility. However, solid organ transplants and HSCT allografts from another donor requires histocompatibility confirmed by human leukocyte antigen (HLA) testing outside of genetically identical twins. This report, Transplant Matching Molecular...Published: April 27, 2017 | Price: $3,196.00 – $6,392.00
This report represents a solid research and benchmarking tool for market planners in diagnostics and laboratory test services for clinical purposes. Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total) Northern America Market Value by Country, 2016 (Canada, United States, Rest of Northern America) U.S. Clinical Laboratory Market Analysis, 2010-2021 U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (Hospital-based, Physician-office, Independent, Total) Clinical Laboratory Market Share by...Published: April 24, 2017 | Price: $200.00 – $400.00
A look at key trends in in vitro diagnostics in the month of April 2017.Published: April 18, 2017 | Price: $3,196.00 – $6,392.00
EMR Market 2017: Electronic Medical Records Market in an Era of Disruption For a decade, the EMR market could be said to be growing market on a predictable trajectory. There is a great deal of competition, hundreds of scattered companies serving local or web markets, and a few large concerns that are capturing large institutions. There were government-funded physician and hospital incentives in the largest market of the United States, which transformed to potential penalties. All the while, some trends...Published: April 17, 2017 | Price: $796.00 – $1,592.00
Out-of-Pocket Healthcare Expenditures in the United States Out-of-Pocket Healthcare Expenditures in the United States examines the average person’s out-of-pocket medical costs, including: Distribution of Out-of-Pocket Spending for the Average Person, 2016, 2021 Consumer Out-of-Pocket Expenditures per Worker, 2011–2021 Consumer Out-of-Pocket Expenditures by Type, 2011–2021 Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2011, 2016, 2021 Average Share Paid Out-of-Pocket by U.S. Residents with Healthcare Spending by Percentile of Total Health Spending and Type of Service, 2016 Average Share...Published: April 17, 2017 | Price: $2,800.00 – $5,600.00
Clinics within stores, particularly drugstores, have already grown to 2,000 in the United States and expanded beyond expectations. This report looks at the retail clinic market and the potential of retail clinics to grow and expand in the future. What clinic brands are leading? How many locations will there be in 5 years? What are IVD and vaccine product sales to retail clinics, and what will those be in 2020? How are retail clinics impacting doctor's offices? This report answers...Published: April 16, 2017 | Price: $3,360.00 – $6,720.00
Across the world infectious disease cases are rising, fueling demand for technologies that can detect them. This report, Infectious Disease Molecular Diagnostics Market, contains market sizing and forecasts for several segments of infectious disease testing: Infectious Disease Market, 2016-2021 HPV Diagnostics Market, 2016 to 2021 RSV Diagnostics Market, 2016 to 2021 Mycobacteria/TB Molecular Diagnostics Market, 2016 to 2021 Other Infectious Disease Molecular Diagnostics Market, 2016 to 2021 Overall Molecular Diagnostic Market, 2016 to 2021 Trends in the Market Market Share...Published: April 12, 2017 | Price: $3,196.00 – $6,392.00
PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportunity estimates for both research and diagnostic uses of PCR, by geography, with forecasts to 2021; global analysis of PCR and other NAAT technologies; examination of the applications of PCR and other NAAT in research and...Published: April 12, 2017 | Price: $2,800.00 – $5,600.00
Cell-Free DNA (cfDNA) Markets details the market opportunity for cfDNA analysis instruments, consumables, kits, and related software. The report provides complete market information, including current market estimates and forecasts to 2021, as well as: Growth Rate for cfDNA Market, 2016-2021 cfDNA Clinical Diagnostics Market, 2016-2021 cfDNA Clinical Diagnostics Market Growth Rate, 2016-2021 cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW) cfDNA Instruments and Consumables Revenues by Product Type, 2016 (Consumables, Systems, Services) Market Share by Company of...Published: April 1, 2017 | Price: $7,996.00 – $15,992.00
This bundle of previously published Kalorama Information studies allows decision-makers and researchers to review critical information in order to be prepared for events coming in 2017. This In Vitro Diagnostics Market bundle contains the following reports, covering a range of IVD topics. The World Market for In Vitro Diagnostics, 10thEdition. Published August 2016 United States In Vitro Diagnostics Markets Published July 2016 Companion Diagnostic Testing Markets Published April 2016 Next Generation Sequencing Markets Published September 2016 These are...Published: March 28, 2017 | Price: $3,600.00 – $7,200.00
Worldwide In Vitro Diagnostics Market 2017: IVD Test Volume and Pricing Analysis The IVD market, defined in procedure volume and pricing tables makes up the market data in this report. Procedure volume estimates are provided for various categories, and average selling price (ASP) for tests are calculated. The report estimates IVD test procedure Volume and IVD Pricing for the following segments Worldwide IVD Market and Test Volume Point-of-Care Market and Test Volume Clinical Chemistry Market and...Published: March 22, 2017 | Price: $3,196.00 – $6,392.00
The World Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement) The World Market for Respiratory Devices provides revenue data for the global and geographic opportunities for respiratory equipment. The report offers information on the entire respiratory equipment market, product estimates by segment, and market revenues by geographical region for 2016-2021, including global respiratory opportunity percentage by type, 2016 and 2021; opportunity size and growth for 2016-2021; opportunity size and growth for...Published: March 22, 2017 | Price: $200.00 – $400.00
Kalorama's current trends in the in vitro diagnostic industry.Published: March 14, 2017 | Price: $200.00 – $400.00
A survey of consumers who visited a retail clinic or an urgent care center, asked questions about visit and satisfaction.Published: March 10, 2017 | Price: $3,600.00 – $7,200.00
Clinical Laboratory Services Market Clinical laboratories offer a wide range of tests and service to meet the needs of the medical industry. Clinical Laboratory Services Market examines the clinical laboratory industry and provides the following information: world clinical laboratory revenues, 2010-2021; top companies, world service sales, 2014, 2015 and 2016; estimated U.S. lab service sales and opportunity share of top clinical lab companies, 2016; estimated U.S. lab service sales for top clinical laboratory companies, 2010 vs. 2016; world clinical lab...Published: February 22, 2017 | Price: $3,600.00 – $7,200.00
Hospital Acquired Infection (HAI) Control Markets Hospital Acquired Infection (HAI) Control Markets provides a revenue analysis for the prevention, testing, and treatment of infections in the healthcare surroundings, including the world revenues for 2010-2021 for hospital infection control, for hospital infection treatment, and for hospital infection prevention equipment and consumables (sterilization/disinfection). Sales information is also provided for the different market segments by primary geographic region (United States, Europe, rest of world) and leading manufacturers’ shares. Merck, Pfizer, GlaxoSmithKline, and Bayer...